Safety implications of concomitant administration of antidepressants and opioid analgesics in surgical patients-Reference-Cited by-同舟云学术

Safety implications of concomitant administration of antidepressants and opioid analgesics in surgical patients

Published:2023-02-22 Issue:6 Volume:22 Page:477-484
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Rodriguez-Monguio Rosa¹²³^ORCID,Lun Zhixin²^ORCID,Dickinson Drew T¹,Do Connie¹,Hyland Bailey¹,Kocharyan Eline¹,Liu Leanne¹,Steinman Michael A⁴

Affiliation:

1. Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, California, USA

2. Medication Outcomes Center, University of California San Francisco, California, USA

3. Philip R. Lee Institute for Health Policy Studies, the University of California San Francisco, California, USA

4. Division of Geriatrics, School of Medicine, University of California San Francisco, California, USA

Funder

National Institutes of Health, National Center for Advancing Translational Sciences

National Institute of Aging

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2023.2181333

Reference34 articles.

1. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013

2. National Center for Health Statistics. Health, United States, 2015: with special feature on racial and ethnic health disparities. Table 80: selected prescription drug classes used in the past 30 days, by sex and age: United States, selected years 1988–1994 through 2009–2012. Hyattsville MD: U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. p. 2016.

3. National Center for Health Statistics, National Health and Nutrition Examination Survey, 2015-2018. Available at: https://www.cdc.gov/nchs/products/databriefs/db377.htm. cited 2022 Apr 26

4. Perioperative Use of Selective Serotonin Reuptake Inhibitors and Risks for Adverse Outcomes of Surgery